These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 34671067)

  • 21. Non-high-density lipoprotein cholesterol levels predict five-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI).
    Bittner V; Hardison R; Kelsey SF; Weiner BH; Jacobs AK; Sopko G;
    Circulation; 2002 Nov; 106(20):2537-42. PubMed ID: 12427648
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of Remnant Lipoprotein on Coronary Plaque Components.
    Matsuo N; Matsuoka T; Onishi S; Yamamoto H; Kato A; Makino Y; Kihara S
    J Atheroscler Thromb; 2015 Aug; 22(8):783-95. PubMed ID: 25739822
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
    Cziraky MJ; Watson KE; Talbert RL
    J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Atherogenic Index of Plasma: A Powerful and Reliable Predictor for Coronary Artery Disease in Patients With Type 2 Diabetes.
    Zhou K; Qin Z; Tian J; Cui K; Yan Y; Lyu S
    Angiology; 2021 Nov; 72(10):934-941. PubMed ID: 33949211
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapid Plaque Progression Is Independently Associated With Hyperglycemia and Low HDL Cholesterol in Patients With Stable Coronary Artery Disease: A PARADIGM Study.
    Neglia D; Caselli C; Maffei E; Cademartiri F; Meloni A; Bossone E; Saba L; Lee SE; Sung JM; Andreini D; Al-Mallah MH; Budoff MJ; Chinnaiyan K; Choi JH; Chun EJ; Conte E; Gottlieb I; Hadamitzky M; Kim YJ; Lee BK; Leipsic JA; Marques H; de Araújo Gonçalves P; Pontone G; Shin S; Stone PH; Samady H; Virmani R; Narula J; Shaw LJ; Bax JJ; Lin FY; Min JK; Chang HJ
    Circ Cardiovasc Imaging; 2024 Jul; 17(7):e016481. PubMed ID: 39012946
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Visit-to-visit variability of lipid measurements as predictors of cardiovascular events.
    Waters DD; Bangalore S; Fayyad R; DeMicco DA; Laskey R; Melamed S; Barter PJ
    J Clin Lipidol; 2018; 12(2):356-366. PubMed ID: 29310989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of niacin in raising high-density lipoprotein cholesterol to reduce cardiovascular events in patients with atherosclerotic cardiovascular disease and optimally treated low-density lipoprotein cholesterol: baseline characteristics of study participants. The Atherothrombosis Intervention in Metabolic syndrome with low HDL/high triglycerides: impact on Global Health outcomes (AIM-HIGH) trial.
    AIM-HIGH Investigators
    Am Heart J; 2011 Mar; 161(3):538-43. PubMed ID: 21392609
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein Cholesterol, Triglycerides, and Apolipoprotein B and Cardiovascular Risk in Patients With Manifest Arterial Disease.
    van den Berg MJ; van der Graaf Y; de Borst GJ; Kappelle LJ; Nathoe HM; Visseren FLJ;
    Am J Cardiol; 2016 Sep; 118(6):804-810. PubMed ID: 27471056
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating Oxidized Low-Density Lipoprotein is a Strong Risk Factor for the Early Stage of Coronary Heart Disease.
    Zhang Q; Ai Y; Dong H; Wang J; Xu L
    IUBMB Life; 2019 Feb; 71(2):277-282. PubMed ID: 30414358
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term prognostic utility of low-density lipoprotein (LDL) triglyceride in real-world patients with coronary artery disease and diabetes or prediabetes.
    Jin JL; Zhang HW; Cao YX; Liu HH; Hua Q; Li YF; Zhang Y; Guo YL; Wu NQ; Zhu CG; Xu RX; Gao Y; Li XL; Cui CJ; Liu G; Sun J; Dong Q; Santos R; Li JJ
    Cardiovasc Diabetol; 2020 Sep; 19(1):152. PubMed ID: 32981521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Study of the Use of Lipid Panels as a Marker of Insulin Resistance to Determine Cardiovascular Risk.
    Bertsch RA; Merchant MA
    Perm J; 2015; 19(4):4-10. PubMed ID: 26517432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Triglyceride/HDL-cholesterol ratio is an independent predictor for coronary heart disease in a population of Iranian men.
    Hadaegh F; Khalili D; Ghasemi A; Tohidi M; Sheikholeslami F; Azizi F
    Nutr Metab Cardiovasc Dis; 2009 Jul; 19(6):401-8. PubMed ID: 19091534
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between plasma phospholipase A2 concentrations and lipoprotein subfractions in patients with stable coronary artery disease.
    Xu RX; Zhang Y; Li XL; Li S; Guo YL; Dong Q; Liu G; Li JJ
    Clin Chim Acta; 2015 Jun; 446():195-200. PubMed ID: 25934512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fractional esterification rate of cholesterol and ratio of triglycerides to HDL-cholesterol are powerful predictors of positive findings on coronary angiography.
    Frohlich J; Dobiásová M
    Clin Chem; 2003 Nov; 49(11):1873-80. PubMed ID: 14578319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The pre-existence of an acute coronary event predicts differences in biological parameters and clinical evolution among patients with longstanding stable angina.
    Sposito AC; Lemos PA; Maranhão RC; Mansur AP; Cesar LA; Ramires JA
    Int J Cardiol; 2003 Oct; 91(2-3):193-200. PubMed ID: 14559130
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative effects of 10-mg versus 80-mg Atorvastatin on high-sensitivity C-reactive protein in patients with stable coronary artery disease: results of the CAP (Comparative Atorvastatin Pleiotropic effects) study.
    Bonnet J; McPherson R; Tedgui A; Simoneau D; Nozza A; Martineau P; Davignon J;
    Clin Ther; 2008 Dec; 30(12):2298-313. PubMed ID: 19167589
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.
    Downs JR; Clearfield M; Weis S; Whitney E; Shapiro DR; Beere PA; Langendorfer A; Stein EA; Kruyer W; Gotto AM
    JAMA; 1998 May; 279(20):1615-22. PubMed ID: 9613910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The beneficial effects of raising high-density lipoprotein cholesterol depends upon achieved levels of low-density lipoprotein cholesterol during statin therapy: Implications for coronary atheroma progression and cardiovascular events.
    Puri R; Nissen SE; Shao M; Kataoka Y; Uno K; Kapadia SR; Tuzcu EM; Nicholls SJ
    Eur J Prev Cardiol; 2016 Mar; 23(5):474-85. PubMed ID: 25691546
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical predictors for progression of nonintervened nonculprit coronary lesions despite low-density lipoprotein cholesterol less than 1.8 mmol/l after successful stent implantation.
    Yin ZX; Zhou YJ; Liu XL; Han HY; Yang SW
    Coron Artery Dis; 2011 Mar; 22(1):49-54. PubMed ID: 21150778
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Independent association of atherogenic dyslipidaemia with all-cause mortality in individuals with type 2 diabetes and modifying effect of gender: a prospective cohort study.
    Orsi E; Penno G; Solini A; Bonora E; Fondelli C; Trevisan R; Vedovato M; Cavalot F; Morano S; Baroni MG; Nicolucci A; Pugliese G;
    Cardiovasc Diabetol; 2021 Jan; 20(1):28. PubMed ID: 33516215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.